The Longevity Labs+ success story
Although our company Longevity Labs+ was founded in 2016, our story begins six years earlier, in 2010, when Prof. Dr. Frank Madeo, considered the "discoverer" of spermidine, was leading research activities on the polyamine spermidine at the University of Graz. In 2016, Dr. Gerald Sitte and DI Herbert Pock (current managing director together with Mag. Petra Pongratz), became aware of Frank Madeo's research and instinctively recognized the importance of this research.
Immediately they started working on a special extraction method together with the researchers of the University of Graz and in this way founded the spin off Longevity Labs+. As a company, we also quickly gained attention outside the University of Graz, so that we have been able to welcome Dr. Hannes Androsch as an investor in our company since 2018.
In 2019, after extensive testing and studies, the first product spermidineLIFE® Original 365+ was launched on the market and was directly among the sales winners in Austrian pharmacies. We celebrated this great success in the spring of 2020 by founding our subsidiary Longevity Labs Inc. in the USA.
When the entire world was faced with completely new challenges in 2020, we did everything we could to support where we could, and in the fall of 2020 we launched the product spermidineLIFE® Immunity+, which specifically supports our immune cells.2 Just six months later, in the spring of 2021, we launched the next innovation: spermidineLIFE® Memory+ for our brain cells.3
With our usual innovative character, we of course already have further market innovations in the pipeline. While these are still being extensively tested, we are focusing on building up our international sales activities, because our vision is to enable as many people around the world as possible to live a healthy life1.